Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Miling Harrington advises clients on a broad range of transactions in the life sciences and technology sectors, including complex licensing and collaboration agreements, strategic acquisitions and divestitures, and commercial arrangements. As a former scientist, Ms. Harrington draws upon her extensive research experience and familiarity with a wide variety of fields and techniques including high throughput sequencing, “Big Data” analytical tools, genomics, microbiology, immunology, the human microbiome, and stem cell biology.

  • Represented an international biotechnology company in a strategic collaboration, option and licensing arrangement with a biotechnology company for the research and development of novel small molecule RNA therapies.
  • Represented an international analytics and decision tools company in its joint venture with a machine learning-based contract analytics company.
  • Represented an international pharmaceutical company in its acquisition of a biopharmaceutical company developing small molecule drug conjugates.